{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:34:12Z","timestamp":1784932452493,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpha.2025.101337","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T13:16:40Z","timestamp":1746796600000},"page":"101337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimizing blood-brain barrier permeability in KRAS inhibitors: A structure-constrained molecular generation approach"],"prefix":"10.1016","volume":"15","author":[{"given":"Xia","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liquan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9547-0643","authenticated-orcid":false,"given":"Xutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101337_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-15-1105","article-title":"Selective inhibition of oncogenic KRAS output with small molecules targeting the inactive state","volume":"6","author":"Patricelli","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jpha.2025.101337_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","article-title":"The current state of the art and future trends in RAS-targeted cancer therapies","volume":"19","author":"Punekar","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jpha.2025.101337_bib3","article-title":"KRAS mutation: From undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101337_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/acs.jmedchem.9b01180","article-title":"Discovery of a covalent inhibitor of KRASG12C (AMG 510) for the treatment of solid tumors","volume":"63","author":"Lanman","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib5","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1021\/acs.jmedchem.9b02052","article-title":"Identification of the clinical development candidate MRTX849, a covalent KRASG12C inhibitor for the treatment of cancer","volume":"63","author":"Fell","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-RasG12C inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101337_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/oncolo\/oyab080","article-title":"Phase I study of JNJ-74699157 in patients with advanced solid tumors harboring the KRASG12C mutation","volume":"27","author":"Wang","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.jpha.2025.101337_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2023.09.1851","article-title":"665P First-in-human, phase Ia\/b, dose-escalation\/expansion study of KRASG12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with advanced or metastatic solid tumours harbouring a KRASG12C mutation","volume":"34","author":"Heymach","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jpha.2025.101337_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJMoa2303810","article-title":"Single-agent divarasib (GDC-6036) in solid tumors with a KRASG12C mutation","volume":"389","author":"Sacher","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2025.101337_bib10","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2021-1259","article-title":"Abstract 1259: Preclinical characterization of LY3537982, a novel, highly selective and potent KRASG12C inhibitor","volume":"81","author":"Peng","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101337_bib11","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1111\/cas.15829","article-title":"D-1553: A novel KRASG12C inhibitor with potent and selective cellular and in vivo antitumor activity","volume":"114","author":"Shi","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jpha.2025.101337_bib12","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1021\/acs.jmedchem.2c00369","article-title":"Discovery of AZD4625, a covalent allosteric inhibitor of the mutant GTPase KRASG12C","volume":"65","author":"Kettle","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/2159-8290.CD-20-0142","article-title":"BI-3406, a potent and selective SOS1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition","volume":"11","author":"Hofmann","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jpha.2025.101337_bib14","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/acs.jmedchem.2c00741","article-title":"Design and discovery of MRTX0902, a potent, selective, brain-penetrant, and orally bioavailable inhibitor of the SOS1: KRAS protein-protein interaction","volume":"65","author":"Ketcham","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib15","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib16","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.1016\/j.jtho.2022.07.794","article-title":"EP08.02-111 RMC-4630, a SHP2 inhibitor, in combination with sotorasib for advanced KRASG12C NSCLC after failure of prior standard therapies: A phase 2 trial","volume":"17","author":"Johnson","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jpha.2025.101337_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-023-00679-y","article-title":"COMA: Efficient structure-constrained molecular generation using contractive and margin losses","volume":"15","author":"Choi","year":"2023","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jpha.2025.101337_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-019-0404-1","article-title":"Mol-CycleGAN: A generative model for molecular optimization","volume":"12","author":"Maziarka","year":"2020","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jpha.2025.101337_bib19","article-title":"FastFlows: Flow-based models for molecular graph generation","author":"Frey","year":"2022","journal-title":"arXiv"},{"key":"10.1016\/j.jpha.2025.101337_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-024-01233-z","article-title":"Geometry-complete diffusion for 3D molecule generation and optimization","volume":"7","author":"Morehead","year":"2024","journal-title":"Commun. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib21","article-title":"Exploring chemical space: Generative models and their evaluation","volume":"3","author":"Vogt","year":"2023","journal-title":"Artif. Intell. Life Sci."},{"key":"10.1016\/j.jpha.2025.101337_bib22","article-title":"Auto-encoding variational bayes","author":"Kingma","year":"2022","journal-title":"arXiv"},{"key":"10.1016\/j.jpha.2025.101337_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Richard Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-021-00498-z","article-title":"Diversity oriented Deep Reinforcement Learning for targeted molecule generation","volume":"13","author":"Pereira","year":"2021","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jpha.2025.101337_bib25","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1021\/acs.jmedchem.9b00959","article-title":"Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism","volume":"63","author":"Xiong","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s43588-023-00529-9","article-title":"Computing the relative binding affinity of ligands based on a pairwise binding comparison network","volume":"3","author":"Yu","year":"2023","journal-title":"Nat. Comput. Sci."},{"key":"10.1016\/j.jpha.2025.101337_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-023-00754-4","article-title":"LogD7.4 prediction enhanced by transferring knowledge from chromatographic retention time, microscopic pKa and LogP","volume":"15","author":"Wang","year":"2023","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jpha.2025.101337_bib28","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: A large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2025.101337_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-99785-0","article-title":"Targeted molecular generation with latent reinforcement learning","volume":"15","author":"Haddad","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101337_bib30","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1039\/b409813g","article-title":"Molecular similarity: A key technique in molecular informatics","volume":"2","author":"Bender","year":"2004","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib31","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1021\/acs.jmedchem.3c00746","article-title":"Discovery of AZD4747, a potent and selective inhibitor of mutant GTPase KRASG12C with demonstrable CNS penetration","volume":"66","author":"Kettle","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib32","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41401-023-01053-2","article-title":"143D, a novel selective KRASG12C inhibitor exhibits potent antitumor activity in preclinical models","volume":"44","author":"Xu","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpha.2025.101337_bib33","doi-asserted-by":"crossref","first-page":"16838","DOI":"10.1021\/acs.jmedchem.1c01683","article-title":"Active learning for drug design: A case study on the plasma exposure of orally administered drugs","volume":"64","author":"Ding","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101337_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-022-00619-2","article-title":"Blood-brain barrier penetration prediction enhanced by uncertainty estimation","volume":"14","author":"Tong","year":"2022","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jpha.2025.101337_bib35","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0031-3203(96)00142-2","article-title":"The use of the area under the ROC curve in the evaluation of machine learning algorithms","volume":"30","author":"Bradley","year":"1997","journal-title":"Pattern Recognit."},{"key":"10.1016\/j.jpha.2025.101337_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-019-6413-7","article-title":"The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation","volume":"21","author":"Chicco","year":"2020","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jpha.2025.101337_bib37","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.623","article-title":"The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation","volume":"7","author":"Chicco","year":"2021","journal-title":"PeerJ Comput. Sci."},{"key":"10.1016\/j.jpha.2025.101337_bib38","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"Van Der Maaten","year":"2008","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.jpha.2025.101337_bib39","article-title":"Reducing overconfident errors in molecular property classification using Posterior Network","volume":"5","author":"Fan","year":"2024","journal-title":"Patterns (N Y)"},{"key":"10.1016\/j.jpha.2025.101337_bib40","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acs.jcim.2c00462","article-title":"An In silico explainable multiparameter optimization approach for de novo drug design against proteins from the central nervous system","volume":"62","author":"Bung","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2025.101337_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41454-9","article-title":"A pharmacophore-guided deep learning approach for bioactive molecular generation","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2025.101337_bib42","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/acs.jcim.1c00600","article-title":"MolGPT: Molecular generation using a transformer-decoder model","volume":"62","author":"Bagal","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2025.101337_bib43","doi-asserted-by":"crossref","first-page":"19575","DOI":"10.1021\/acsomega.3c01078","article-title":"Molecular graph generation by decomposition and reassembling","volume":"8","author":"Yamada","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpha.2025.101337_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpha.2025.101337_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33414-6","article-title":"Pareto optimization with small data by learning across common objective spaces","volume":"13","author":"Tan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101337_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/349781","article-title":"A multiobjective genetic algorithm based on a discrete selection procedure","volume":"2015","author":"Long","year":"2015","journal-title":"Math. Probl. Eng."},{"key":"10.1016\/j.jpha.2025.101337_bib47","article-title":"The blood-brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101337_bib48","article-title":"Towards foundational models for molecular learning on large-scale multi-task datasets","author":"Beaini","year":"2023","journal-title":"arXiv"},{"key":"10.1016\/j.jpha.2025.101337_bib49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06139-9","article-title":"Transfer learning enables predictions in network biology","volume":"618","author":"Theodoris","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101337_bib50","article-title":"Continuously indexed domain adaptation","author":"Wang","year":"2020","journal-title":"arXiv"}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T09:55:22Z","timestamp":1758189322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2095177925001546"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101337","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing blood-brain barrier permeability in KRAS inhibitors: A structure-constrained molecular generation approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101337"}}